[1] 田太郎.ィンソリン抵抗性の臨床的指[J].臨床とホルモン.2001, 249∶51-57.
|
[2]Collins S, Kuhn CM, Petro AE, et al.Role of leptin in fatregulation[J].Nature, 1996, 25∶380 (6576) ∶677.
|
[3]Chitturi S, Farrell G, Frost L, et al.Serum leptin in NASH corre-lates with hepatic steatosis but not fibrosis:a manifestation of lipotox-icity[J].Hepatology, 2002, 36 (2) ∶403-409.
|
[4]Kieffer JJ, Heller RS, Leech CA, et al.Leptin suppression of insu-lin secretion by the activation of ATP-sen sitive K+channels.inpancreaticβ-cells[J].Diabetes, 1997, 46 (6) ∶1087-1093.
|
[5]Yahagi N, Shimano H, Alyssa H, et al.Absence of sterol regulatoryelement Obinding proteinO1 (SREBPO1) amelioratesfatty livers butnot obesity or insulin resistance in Lepob/Lep-ob mice[J].J BiolChem, 2002, 277∶19353~19357.
|
[1] | Sulian YANG, Rongjie SHI, Lihua LI. Value of Fetuin-A, Fetuin-B, and insulin resistance index in predicting nonalcoholic fatty liver disease[J]. Journal of Clinical Hepatology, 2024, 40(4): 694-699. doi: 10.12449/JCH240409 |
[2] | Heng ZHU, Weizong KONG, Guiqun HUANG, Yu BAI, Yingchun WANG. Influence of histone deacetylase 1 on insulin resistance in a cell model of nonalcoholic fatty liver disease[J]. Journal of Clinical Hepatology, 2022, 38(9): 2010-2015. doi: 10.3969/j.issn.1001-5256.2022.09.013 |
[3] | Dou AiHua, Hui Wei, Liu Mei, Wei LinLin, Zhao Juan, Ma ChunHua, Zheng XiaoQin, Xiong Fang, Yang Xue, Zhang Mei, Xu Bin. Association between rs2943650 mutation and insulin resistance in patients with chronic liver disease and type 2 diabetes mellitus[J]. Journal of Clinical Hepatology, 2018, 34(11): 2379-2382. doi: 10.3969/j.issn.1001-5256.2018.11.022 |
[4] | Ding ZhiYong, Bu Le, Lu HongYan, Rao ZhengXuan. Correlation of liver fat content with serum vitamin A level and insulin resistance in patients with nonalcoholic fatty liver disease[J]. Journal of Clinical Hepatology, 2017, 33(12): 2361-2365. doi: 10.3969/j.issn.1001-5256.2017.12.021 |
[5] | Liu DaJi, Chen QingFeng. Pathogenesis of insulin resistance and its impact on antiviral therapy in patients with chronic hepatitis C[J]. Journal of Clinical Hepatology, 2017, 33(6): 1152-1155. doi: 10.3969/j.issn.1001-5256.2017.06.029 |
[6] | Wang CuiHua, Yue Yan. Research progress in relationship of leptin and adiponectin with non-alcoholic fatty liver disease[J]. Journal of Clinical Hepatology, 2015, 31(8): 1351-1354. doi: 10.3969/j.issn.1001-5256.2015.08.045 |
[7] | Zhang QiuNan, Xiao Ying, Miao RuiXin, Zhang YaQing, Zhu Ying. Changes in intestinal flora in nonalcoholic fatty liver disease: their correlation with insulin resistance index,tumor necrosis factor- α,and interleukin- 6[J]. Journal of Clinical Hepatology, 2015, 31(7): 1078-1081. doi: 10.3969/j.issn.1001-5256.2015.07.019 |
[8] | Pan Jing, Yin YunQin, Zhang WenPing, Wang Dan. Experimental study on role of cannabinoid receptor 1 in non-alcoholic fatty liver disease among rats[J]. Journal of Clinical Hepatology, 2013, 29(8): 611-615. doi: 10.3969/j.issn.1001-5256.2013.08.015 |
[9] | Kong Yin, Zhang LingYi. The role of leptin and adiponectin in non-alcoholic fatty liver disease[J]. Journal of Clinical Hepatology, 2011, 27(4): 441-443. |
[10] | Ma LiNa, Feng Ming, Zhou YingZhi, Ma Jia, Hao Peng. The relationship between nonalcoholic fatty liver disease and insulin resistance[J]. Journal of Clinical Hepatology, 2010, 26(2): 173-174+177. |
[11] | Wang ChunPing, Zhang Ming. Evaluation of leptin receptor Gln223Arg polymorphism in patients with non-alcoholic fatty liver disease[J]. Journal of Clinical Hepatology, 2008, 24(3): 194-196. |
[12] | Yu XiaoHu, Zhu JinShui, Gu GuoMei, Shi JianPing. Clinical effect of oxymatrine combined with metformin on insulin resistance and serum TNF-α in patients with non-alcoholic fatty liver[J]. Journal of Clinical Hepatology, 2007, 23(3): 195-196. |
[13] | Zhang FenMing, Gao SuQin, Kong DeZhi. Relationship between nonalcoholic fatty liver disease and insulin resistance in hypertensive patients[J]. Journal of Clinical Hepatology, 2007, 23(4): 277-279. |
[14] | Zheng JiMin, Jiang HuiQing, Lu: XiaoPing, Zhang XiangMei. Measurement of ghrelin leptin levels in patients with liver cirrhosis[J]. Journal of Clinical Hepatology, 2006, 22(3): 195-196. |
[16] | Lu ZhenYa, Wang QunYan, Rao WeiQiang, Cai WeiMin. Relationship between leptin resistance and nonalcoholic fatty liver in male patients.[J]. Journal of Clinical Hepatology, 2006, 22(1): 39-41. |
[17] | Liang Bing, Chen Xi, Liu ShuangYan, Wang YiGe, An QiuHong. The relationship between non-alcoholic fatty liver disease and insulin resistance[J]. Journal of Clinical Hepatology, 2006, 22(3): 213-214. |
[19] | Huang JiLiang, Wu Fang, Zhang XinRan, Wang DongHua, Zhao RuiZhi. Relationship between tumor necrosis factor-α and lnsulin resistance in patients with liver cirrhosis[J]. Journal of Clinical Hepatology, 2002, 18(3): 166-167. |
[20] | Ma YingJie, Fang LiFeng, Feng SuPing, Jia KeLi, Fu ZhenLie. Obesity and insulin resistance in nonalcoholic fatty liver[J]. Journal of Clinical Hepatology, 2002, 18(4): 241-242. |